Jewell Martin serves as the Director for US Policy on the Global R&D and Regulatory Policy team at BioMarin Pharmaceutical Inc. Prior to joining BioMarin in 2020, Jewell spent 10 years at the US Food and Drug Administration (FDA), where she served in multiple roles including as the Executive Operations Staff Lead in the Office of New Drugs, in the Center for Drug Evaluation and Research (CDER). Jewell received her MA in Medical Sciences from Boston University and MBA from Howard University in Washington, DC. Additionally, she received certifications including the Project Management Professional (PMP) and Regulatory Affairs Certification (RAC).